Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL1201087

CABERGOLINE
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
C=CCN1C[C@H](C(=O)N(CCCN(C)C)C(=O)NCC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21

Basic Information

ChEMBL ID CHEMBL1201087
Name CABERGOLINE
Phase Approved
Structure Type MOL
InChI Key KORNTPPJEAJQIU-KJXAQDMKSA-N
Therapeutic ✓ Yes

Known Names

Cabaser Cabergolina Cabergoline Dostinex FCE 21336 FCE-21336 Velactis
5
Targets
8
Activities
2
Assay Types
0
PK Parameters
20
Publications
7
Known Names
15
Indications
1
Mechanisms

Molecular Properties

451.6
MW (Da)
3.19
ALogP
4
HBA
2
HBD
71.7
PSA (Ų)
0.60
QED
0
Ro5 Violations
8
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 1996
Availability Prescription
Chirality Single Enantiomer

Routes of Administration

Oral

Flags

Natural Product
USAN Stem -erg-
USAN Year 1996

Extended Properties

Molecular Formula C26H37N5O2
MW 451.62
Aromatic Rings 2
Heavy Atoms 33
NP-Likeness 0.03

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Dopamine D2 receptor agonist AGONIST D(2) dopamine receptor

Indications

Parkinson Disease Pituitary Neoplasms Diabetes Mellitus Ovarian Hyperstimulation Syndrome Restless Legs Syndrome Cocaine-Related Disorders Cocaine-Related Disorders Endometriosis Infertility Paget Disease, Extramammary Pituitary ACTH Hypersecretion Polycystic Ovary Syndrome Obesity Substance-Related Disorders Breast Neoplasms

ATC Classification

G02CB03
cabergoline
Level 1: GENITO URINARY SYSTEM AND SEX HORMONES
Level 2: OTHER GYNECOLOGICALS
N04BC06
cabergoline
Level 1: NERVOUS SYSTEM
Level 2: ANTI-PARKINSON DRUGS

Activity Summary

Ki 5 meas. best 9.44
EC50 3 meas. best 7.89

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
D(2) dopamine receptor
CHEMBL217
Ki 9.44 9.44 0.4 2
5-hydroxytryptamine receptor 2B
CHEMBL1833
Ki 8.85 8.85 1.4 1
D(1A) dopamine receptor
CHEMBL2056
Ki 8.85 7.135 1.4 2
5-hydroxytryptamine receptor 2B
CHEMBL1833
EC50 7.89 7.89 13.0 1
Dopamine receptor
CHEMBL2096905
EC50 7.89 7.89 13.0 1
Alpha-2A adrenergic receptor
CHEMBL1867
EC50 6.54 6.54 285.4 1

Activity Data Samples

Top measurements by pChEMBL value

Literature References

PubMed DOI Target Context # Activities
- 10.6019/CHEMBL5724801 HEK-293T 304
- 10.6019/CHEMBL5058577 Fibroblast 304
- 10.6019/CHEMBL5058577 U2OS 304
- 10.6019/CHEMBL5058577 HEK-293T 304
- 10.6019/CHEMBL5724801 U2OS 304
- 10.6019/CHEMBL5724801 Fibroblast 304
16472241 10.2174/1570163043334794 Hepatotoxicity 18
22194678 10.1371/journal.pcbi.1002310 Hepatotoxicity 14
- 10.6019/CHEMBL5209801 Free fatty acid receptor 4 8
- 10.6019/CHEMBL5209801 Apelin receptor 8
- 10.6019/CHEMBL5209801 Sphingosine 1-phosphate receptor 1 8
- 10.6019/CHEMBL5209801 Beta-2 adrenergic receptor 8
- 10.6019/CHEMBL5209801 Adhesion G-protein coupled receptor F1 8
- 10.6019/CHEMBL5209801 N-formyl peptide receptor 2 8
- 10.6019/CHEMBL5209801 CX3C chemokine receptor 1 8
- 10.6019/CHEMBL5209801 C5a anaphylatoxin chemotactic receptor 1 8
- 10.6019/CHEMBL5209801 Glucagon-like peptide 1 receptor 8
- 10.6019/CHEMBL5209801 Alpha-2A adrenergic receptor 8
- 10.6019/CHEMBL5209801 Glucose-dependent insulinotropic receptor 8
- 10.6019/CHEMBL5209801 Type-1 angiotensin II receptor 8

Data from ChEMBL 36 via Core Engine